Pichurin P N, Chen Chun-Rong, Nagayama Y, Pichurina O, Rapoport B, McLachlan S M
Autoimmune Disease Unit, Cedars-Sinai Research Institute and UCLA School of Medicine, Los Angeles, CA, USA.
Clin Exp Immunol. 2004 Mar;135(3):391-7. doi: 10.1111/j.1365-2249.2004.02399.x.
Immunization with thyrotropin receptor (TSHR)-adenovirus is an effective approach for inducing thyroid stimulating antibodies and Graves' hyperthyroidism in BALB/c mice. In contrast, mice of the same strain vaccinated with TSHR-DNA have low or absent TSHR antibodies and their T cells recognize restricted epitopes on the TSHR. In the present study, we tested the hypothesis that immunization with TSHR-adenovirus induces a wider, or different, spectrum of TSHR T cell epitopes in BALB/c mice. Because TSHR antibody levels rose progressively from one to three TSHR-adenovirus injections, we compared T cell responses from mice immunized once or three times. Mice in the latter group were subdivided into animals that developed hyperthyroidism and those that remained euthyroid. Unexpectedly, splenocytes from mice immunized once, as well as splenocytes from hyperthyroid and euthyroid mice (three injections), all produced interferon-gamma in response to the same three synthetic peptides (amino acid residues 52-71, 67-86 and 157-176). These peptides were also the major epitopes recognized by TSHR-DNA plasmid vaccinated mice. We observed lesser responses to a wide range of additional peptides in mice injected three times with TSHR-adenovirus, but the pattern was more consistent with increased background 'noise' than with spreading from primary epitopes to dominant secondary epitopes. In conclusion, these data suggest that factors other than particular TSHR T cell epitopes (such as adenovirus-induced expression of conformationally intact TSHR protein), contribute to the generation of thyroid stimulating antibodies with consequent hyperthyroidism in TSHR-adenovirus immunized mice.
用促甲状腺素受体(TSHR)腺病毒免疫是在BALB/c小鼠中诱导甲状腺刺激抗体和格雷夫斯甲亢的有效方法。相比之下,用TSHR-DNA疫苗接种的同品系小鼠TSHR抗体水平低或无,且其T细胞识别TSHR上的有限表位。在本研究中,我们检验了这样一个假设,即用TSHR腺病毒免疫可在BALB/c小鼠中诱导更广泛或不同的TSHR T细胞表位谱。由于TSHR抗体水平从一次到三次TSHR腺病毒注射逐渐升高,我们比较了单次免疫或三次免疫小鼠的T细胞反应。后一组小鼠又分为发生甲亢的动物和仍为甲状腺功能正常的动物。出乎意料的是,单次免疫小鼠的脾细胞以及甲亢和甲状腺功能正常小鼠(三次注射)的脾细胞,对相同的三种合成肽(氨基酸残基52-71、67-86和157-176)均产生γ干扰素。这些肽也是接种TSHR-DNA质粒小鼠识别的主要表位。我们观察到,三次注射TSHR腺病毒的小鼠对多种其他肽的反应较小,但这种模式更符合背景“噪音”增加,而不是从主要表位扩散到主要次要表位。总之,这些数据表明,除了特定的TSHR T细胞表位之外的因素(如腺病毒诱导的构象完整的TSHR蛋白表达),有助于在接种TSHR腺病毒的小鼠中产生甲状腺刺激抗体并导致甲亢。